Sagefield Capital LP Albemarle Corp Transaction History

Sagefield Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$92.77 - $135.46 $976,125 - $1.43 Million	-10,522 Reduced 23.59%	34,076 $3.25 Million
Q1 2024 May 15, 2024	BUY	$108.73 - $146.89 $1.93 Million - $2.61 Million	17,741 Added 66.06%	44,598 $5.88 Million
Q4 2023 Feb 14, 2024	BUY	$113.26 - $170.8 $287,227 - $433,148	2,536 Added 10.43%	26,857 $3.88 Million
Q3 2023 Nov 14, 2023	BUY	$162.63 - $243.44 $3.54 Million - $5.3 Million	21,781 Added 857.52%	24,321 $4.14 Million
Q2 2023 Aug 14, 2023	BUY	$172.91 - $232.22 $439,191 - $589,838	2,540 New	2,540 $566,000
Q2 2022 Aug 15, 2022	SELL	$187.76 - $270.92 $314,498 - $453,791	-1,675 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$172.09 - $246.0 $288,250 - $412,050	1,675 New	1,675 $371,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Sagefield Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sagefield Capital LP with notifications on news.